Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

δ-Buthitoxin-Hj2a

δ-Buthitoxin-Hj2a, a scorpion-venom peptide, is a potent NaV1.1 agonist with an EC50 of 32 nM. δ-Buthitoxin-Hj2a can be used for the Dravet syndrome (DS) research[1].

Product Specifications

UNSPSC

12352209

Target

Sodium Channel

Type

Peptides

Related Pathways

Membrane Transporter/Ion Channel

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/δ-buthitoxin-hj2a.html

Solubility

10 mM in DMSO

Smiles

O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(O)=O)C(N[C@@H](C)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](C)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC(N)=O)C(N[C@@H](CSSC[C@@H](C(N[C@@H](CCCNC(N)=N)C(N)=O)=O)NC2=O)C(N[C@@H](C(C)C)C(N[C@@H](CC3=CC=C(C=C3)O)C(N[C@@H]([C@H](O)C)C(N[C@@H](CSSC[C@@H](C(N[C@@H](CCC(N)=O)C(N[C@@H](CC4=CNC5=CC=CC=C45)C(N[C@@H](CC(C)C)C(NCC(N[C@@H](CCCCN)C(N[C@@H](CC6=CC=C(C=C6)O)C(NCC(N[C@@H](CC(N)=O)C(NC7)=O)=O)=O)=O)=O)=O)=O)=O)=O)NC8=O)C(N[C@@H](C)C(N[C@@H](CCCCN)C(N[C@@H](CC(N)=O)C(N[C@@H](CO)C(N[C@@H](CC9=CC=C(C=C9)O)C(N[C@@H](CSSC[C@@H](C(N[C@H]%10CC%11=CNC%12=CC=CC=C%11%12)=O)NC7=O)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(N)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CSSC[C@@H](C(N[C@@H](CCCCN)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(C)C)C(N%13[C@@H](CCC%13)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](C(C)C)C(N%14[C@@H](CCC%14)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCNC(N)=N)C(N[C@@H]([C@@H](C)CC)C(N%15[C@@H](CCC%15)C(NCC(N%16[C@H]2CCC%16)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)NC%10=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCCCN)C(N[C@@H](CC(N)=O)C(NCC(N[C@@H](C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CO)C(NCC(N[C@H]8CC%17=CC=C(C=C%17)O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CN

Molecular Formula

C304H458N90O93S8

Molecular Weight

7117.96

References & Citations

[1]Chun Yuen Chow, et al. Venom Peptides with Dual Modulatory Activity on the Voltage-Gated Sodium Channel NaV1.1 Provide Novel Leads for Development of Antiepileptic Drugs. ACS Pharmacol Transl Sci. 2019 Nov 25;3 (1) :119-134.

Shipping Conditions

Room temperature

Scientific Category

Peptides

Clinical Information

No Development Reported

Isoform

Nav1.1

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

JG-2016
BA4770-5.1 1 mL (10 mM in DMSO)

JG-2016

Sign In for Pricing
View Details
ZEB1 polyclonal antibody
orb1724922-01 50 µL

ZEB1 polyclonal antibody

Sign In for Pricing
View Details
ZEB1 polyclonal antibody
orb1724922-02 100 µL

ZEB1 polyclonal antibody

Sign In for Pricing
View Details
Recombinant Human GLS, N-His
ARO-P14232-01 50 µg

Recombinant Human GLS, N-His

Sign In for Pricing
View Details
Recombinant Human GLS, N-His
ARO-P14232-02 100 µg

Recombinant Human GLS, N-His

Sign In for Pricing
View Details
Recombinant Human GLS, N-His
ARO-P14232-03 1 mg

Recombinant Human GLS, N-His

Sign In for Pricing
View Details